The effects of impaired cerebral circulation on Alzheimer's disease pathology: Evidence from animal studies

Journal of Alzheimer's Disease

Volumn 42, Issue 3, 2014, Pages 707-722

  Villarreal, Alcibiades E ^a,b   Barron, Rachel ^c   Rao, K S ^a   Britton, Gabrielle B ^a  

^a INSTITUTO DE INVESTIGACIONES CIENTÍFICAS Y SERVICIOS DE ALTA TECNOLOGÍA   (Panama)

^b ACHARYA NAGARJUNA UNIVERSITY   (India)

^c LAFAYETTE COLLEGE   (United States)

Author keywords

Amyloid ; apolipoprotein E; cerebral amyloid angiopathy; cerebral hypoxia; ischemia; tau protein

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; BRAIN HYPOXIA; BRAIN ISCHEMIA; GENETIC RISK; HEAD INJURY; HUMAN; NONHUMAN; REVIEW; RODENT MODEL; SIGNAL TRANSDUCTION; ANIMAL; BRAIN CIRCULATION; COMPLICATION; DISEASE MODEL; PATHOLOGY; PHYSIOLOGY;

ALZHEIMER DISEASE; ANIMALS; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; HUMANS;

EID: 84907155884     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-140144     Document Type: Review

References (112)

1. Ciobica A, Padurariu M, Bild W, Stefanescu C (2011) Cardiovascular risk factors as potential markers for mild cognitive impairment and Alzheimer's disease. Psychiatr Danub 23, 340-346.
2. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, JonesE(2011) Alzheimer's disease. Lancet 377, 1019-1031.
3. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Pogress and problems on the road to therapeutics. Science 297, 353-356.
4. Khan S, Davies IB (2008) Hypoxia and Alzheimer disease. CMAJ 178, 1687; author reply 1687-1688.
5. Yao L, Kan EM, Lu J, Hao A, Dheen ST, Kaur C, Ling EA (2013) Toll-like receptor 4 mediates microglial activation and production of inflammatory mediators in neonatal rat brain following hypoxia: Role of TLR4 in hypoxic microglia. J Neuroinflammation 10, 23.
6. Kaur C, Ling EA (2009) Periventricular white matter damage in the hypoxic neonatal brain: Role of microglial cells. Prog Neurobiol 87, 264-280.
7. Fernandez PL, Britton GB, Rao KS (2013) Potential immunotargets for Alzheimer's disease treatment strategies. J Alzheimers Dis 33, 297-312.
8. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269.
9. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, FaganAM, IwatsuboT, JackCRJr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292.
10. Korczyn AD, Vakhapova V, Grinberg LT (2012) Vascular dementia. J Neurol Sci 322, 2-10.
11. Pohjasvaara T, Mantyla R, Ylikoski R, Kaste M, Erkinjuntti T (2000) Comparison of different clinical criteria (DSMIII, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences. Stroke 31, 2952-2957.
12. Chui HC, Mack W, Jackson JE, Mungas D, Reed BR, Tinklenberg J, Chang FL, Skinner K, Tasaki C, Jagust WJ (2000) Clinical criteria for the diagnosis of vascular dementia: A multicenter study of comparability and interrater reliability. Arch Neurol 57, 191-196.
13. Langa KM, Foster NL, Larson EB (2004) Mixed dementia: Emerging concepts and therapeutic implications. JAMA292, 2901-2908.
14. Jellinger KA (2008) Morphologic diagnosis of "vascular dementia"-a critical update. J Neurol Sci 270, 1-12.
15. Iadecola C (2010) The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol 120, 287-296.
16. Yager JY, Wright S, Armstrong EA, Jahraus CM, Saucier DM (2006) The influence of aging on recovery following ischemic brain damage. Behav Brain Res 173, 171-180.
17. Peers C, Dallas ML, Boycott HE, Scragg JL, Pearson HA, Boyle JP (2009) Hypoxia and neurodegeneration. Ann N Y Acad Sci 1177, 169-177.
18. Gusnard DA, Raichle ME (2001) Searching for a baseline: Functional imaging and the resting human brain. Nat Rev Neurosci 2, 685-694.
19. Leithner C, RoylG(2014) The oxygen paradox of neurovascular coupling. J Cereb Blood Flow Metab 34, 19-29.
20. Austin BP, Nair VA,Meier TB, Xu G, Rowley HA, Carlsson CM, Johnson SC, Prabhakaran V (2011) Effects of hypoperfusion in Alzheimer's disease. J Alzheimers Dis 26(Suppl 3), 123-133.
21. Caplan LR, Hennerici M (1998) Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 55, 1475-1482.
22. Brumm KP, Perthen JE, Liu TT, Haist F, Ayalon L, Love T (2010) An arterial spin labeling investigation of cerebral blood flow deficits in chronic stroke survivors. Neuroimage 51, 995-1005.
23. Roman G, Pascual B (2012) Contribution of neuroimaging to the diagnosis of Alzheimer's disease and vascular dementia. Arch Med Res 43, 671-676.
24. Vila N, Castillo J, Davalos A, Chamorro A (2000) Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31, 2325-2329.
25. Politis M, Su P, Piccini P (2012) Imaging of microglia in patients with neurodegenerative disorders. Front Pharmacol 3, 96.
26. Zhang X, Le W (2010) Pathological role of hypoxia in Alzheimer's disease. Exp Neurol 223, 299-303.
27. Launer LJ, Hughes TM, White LR (2011) Microinfarcts, brain atrophy, and cognitive function: The Honolulu Asia Aging Study Autopsy Study. Ann Neurol 70, 774-780.
28. Suter OC, Sunthorn T, Kraftsik R, Straubel J, Darekar P, Khalili K, Miklossy J (2002) Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke 33, 1986-1992.
29. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA (2004) Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology 62, 1148-1155.
30. Zetterberg H, Mortberg E, Song L, Chang L, Provuncher GK, Patel PP, Ferrell E, Fournier DR, Kan CW, Campbell TG, Meyer R, Rivnak AJ, Pink BA, Minnehan KA, Piech T, Rissin DM, Duffy DC, Rubertsson S, Wilson DH, Blennow K (2011) Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid beta levels in humans. PLoS One 6, e28263.
31. Chen GJ, Xu J, Lahousse SA, Caggiano NL, de la MonteSM (2003) Transient hypoxia causes Alzheimer-type molecular and biochemical abnormalities in cortical neurons: Potential strategies for neuroprotection. J Alzheimers Dis 5, 209-228.
32. Jendroska K, Hoffmann OM, Patt S (1997) Amyloid beta peptide and precursor protein (APP) in mild and severe brain ischemia. Ann N Y Acad Sci 826, 401-405.
33. Shi J, Yang SH, Stubley L, Day AL, Simpkins JW (2000) Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model. Brain Res 853, 1-4.
34. Ogunshola OO, AntoniouX(2009) Contribution of hypoxia to Alzheimer's disease: Is HIF-1alpha a mediator of neurodegeneration Cell Mol Life Sci 66, 3555-3563.
35. LaFerla FM (2002) Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci 3, 862-872.
36. Geldmacher DS (2010) Alzheimer disease prevention: Focus on cardiovascular risk, not amyloid Cleve Clin J Med 77, 689-704.
37. Prince M, Acosta D, Ferri CP, Guerra M, Huang Y, Rodriguez JJ, Salas A, Sosa AL, Williams JD, Dewey ME, Acosta I, Jotheeswaran AT, Liu Z (2012) Dementia incidence and mortality in middle-income countries, and associations with indicators of cognitive reserve: A 10/66 Dementia Research Group population-based cohort study. Lancet 380, 50-58.
38. Ainslie PN, Cotter JD, George KP, Lucas S, Murrell C, Shave R, Thomas KN,Williams MJ, AtkinsonG(2008) Elevation in cerebral blood flow velocity with aerobic fitness throughout healthy human ageing. J Physiol 586, 4005-4010.
39. Choi SY, Oh BH, Bae Park J, Choi DJ, Rhee MY, Park S (2013) Age-associated increase in arterial stiffness measured according to the cardio-ankle vascular index without blood pressure changes in healthy adults. J Atheroscler Thromb 20, 911-923.
40. Buee L, Hof PR, Bouras C, Delacourte A, Perl DP,Morrison JH, Fillit HM (1994) Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol 87, 469-480.
41. Ewers M, Mielke MM, Hampel H (2010) Blood-based biomarkers of microvascular pathology in Alzheimer's disease. Exp Gerontol 45, 75-79.
42. Castellani RJ, Rolston RK, Smith MA (2010) Alzheimer disease. Dis Mon 56, 484-546.
43. Correia SC, Moreira PI (2010) Hypoxia-inducible factor 1: A new hope to counteract neurodegeneration J Neurochem 112, 1-12.
44. Kim SY, Choi YJ, Joung SM, Lee BH, Jung YS, Lee JY (2010) Hypoxic stress up-regulates the expression of Tolllike receptor 4 in macrophages via hypoxia-inducible factor. Immunology 129, 516-524.
45. Heneka MT, Sastre M, Dumitrescu-Ozimek L, Dewachter I,Walter J, Klockgether T, Van Leuven F (2005) Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice. J Neuroinflammation 2, 22.
46. Bell RD, Zlokovic BV (2009) Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol 118, 103-113.
47. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691.
48. Fang F, Lue LF, Yan S, Xu H, Luddy JS, Chen D, Walker DG, Stern DM, Schmidt AM, Chen JX, Yan SS (2010) RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease. FASEB J 24, 1043-1055.
49. Lee CY, Landreth GE (2010) The role of microglia in amyloid clearance from the AD brain. J Neural Transm 117, 949-960.
50. Deane R, Singh I, Sagare AP, Bell RD, Ross NT, LaRue B, Love R, Perry S, Paquette N, Deane RJ, Thiyagarajan M, Zarcone T, Fritz G, Friedman AE, Miller BL, Zlokovic BV (2012) A multimodal RAGE-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of Alzheimer disease. J Clin Invest 122, 1377-1392.
51. Meraz-Rios MA, Lira-De Leon KI, Campos-Pena V, De Anda-Hernandez MA,Mena-LopezR(2010) Tau oligomers and aggregation in Alzheimer's disease. J Neurochem 112, 1353-1367.
52. Pluta R, Barcikowska M, Mossakowski MJ, Zelman I (1998) Cerebral accumulation of beta-amyloid following ischemic brain injury with long-term survival. Acta Neurochir Suppl 71, 206-208.
53. Qi JP, Wu H, Yang Y, Wang DD, Chen YX, Gu YH, Liu T (2007) Cerebral ischemia and Alzheimer's disease: The expression of amyloid-beta and apolipoprotein E in human hippocampus. J Alzheimers Dis 12, 335-341.
54. Chen XH, Johnson VE, Uryu K, Trojanowski JQ, Smith DH (2009) A lack of amyloid beta plaques despite persistent accumulation of amyloid beta in axons of long-term survivors of traumatic brain injury. Brain Pathol 19, 214-223.
55. Ikonomovic MD, Uryu K, Abrahamson EE, Ciallella JR, Trojanowski JQ, Lee VM, Clark RS, Marion DW, Wisniewski SR, DeKosky ST (2004) Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp Neurol 190, 192-203.
56. Uryu K, Chen XH, Martinez D, Browne KD, Johnson VE, Graham DI, Lee VM, Trojanowski JQ, Smith DH (2007) Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans. Exp Neurol 208, 185-192.
57. Skoog I, Gustafson D (2006) Update on hypertension and Alzheimer's disease. Neurol Res 28, 605-611.
58. Koike MA, Green KN, Blurton-Jones M, Laferla FM (2010) Oligemic hypoperfusion differentially affects tau and amyloid-{beta}. Am J Pathol 177, 300-310.
59. Ksiezak-Reding H, He D, Gordon-Krajcer W, Kress Y, Lee S, Dickson DW(2000) Induction of Alzheimer-specific Tau epitope AT100 in apoptotic human fetal astrocytes. Cell Motil Cytoskeleton 47, 236-252.
60. KoikeMA, Garcia FG, Kitazawa M, Green KN, Laferla FM (2011) Long term changes in phospho-APP and tau aggregation in the 3xTg-AD mice following cerebral ischemia. Neurosci Lett 495, 55-59.
61. Koike MA, Lin AJ, Pham J, Nguyen E, Yeh JJ, Rahimian R, Tromberg BJ, Choi B, Green KN, LaFerla FM (2012) APP knockout mice experience acute mortality as the result of ischemia. PLoS One 7, e42665.
62. Gao L, Tian S, Gao H, Xu Y (2013) Hypoxia increases abeta-induced tau phosphorylation by calpain and promotes behavioral consequences inADtransgenic mice. J Mol Neurosci 51, 138-147.
63. Li L, Zhang X, Yang D, Luo G, Chen S, Le W (2009) Hypoxia increases Abeta generation by altering beta-and gamma-cleavage of APP. Neurobiol Aging 30, 1091-1098.
64. Sun X, He G, Qing H, Zhou W, Dobie F, Cai F, Staufenbiel M, Huang LE, Song W (2006) Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci USA 103, 18727-18732.
65. Yamada M, Ihara M, Okamoto Y, Maki T,Washida K, Kitamura A, Hase Y, Ito H, Takao K, Miyakawa T, Kalaria RN, Tomimoto H, Takahashi R (2011) The influence of chronic cerebral hypoperfusion on cognitive function and amyloid beta metabolism in APP overexpressing mice. PLoS One 6, e16567.
66. Gao B, Long Z, Zhao L, He G (2011) Effect of normobaric hyperoxia on behavioral deficits and neuropathology in Alzheimer's disease mouse model. J Alzheimers Dis 27, 317-326.
67. Beckmann N, Schuler A, Mueggler T, Meyer EP, Wiederhold KH, Staufenbiel M, Krucker T (2003) Age-dependent cerebrovascular abnormalities and blood flow disturbances in APP23 mice modeling Alzheimer's disease. J Neurosci 23, 8453-8459.
68. Klohs J, Baltes C, Princz-Kranz F, Ratering D, Nitsch RM, Knuesel I, Rudin M (2012) Contrast-enhanced magnetic resonance microangiography reveals remodeling of the cerebral microvasculature in transgenic ArcAbeta mice. J Neurosci 32, 1705-1713.
69. Kalaria RN, Akinyemi R, Ihara M (2012) Does vascular pathology contribute to Alzheimer changes J Neurol Sci 322, 141-147.
70. Thal DR, Capetillo-Zarate E, Larionov S, Staufenbiel M, Zurbruegg S, Beckmann N (2009) Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flowdisturbances. Neurobiol Aging 30, 1936-1948.
71. Fryer JD, Simmons K, Parsadanian M, Bales KR, Paul SM, Sullivan PM, Holtzman DM (2005) Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model. J Neurosci 25, 2803-2810.
72. Choi BR, Lee SR, Han JS, Woo SK, Kim KM, Choi DH, Kwon KJ, Han SH, Shin CY, Lee J, Chung CS, Kim HY (2011) Synergistic memory impairment through the interaction of chronic cerebral hypoperfusion and amlyloid toxicity in a rat model. Stroke 42, 2595-2604.
73. Popa-Wagner A, Schroder E, Walker LC, Kessler C (1998) beta-Amyloid precursor protein and ss-amyloid peptide immunoreactivity in the rat brain after middle cerebral artery occlusion: Effect of age. Stroke 29, 2196-2202.
74. Han F, Ali Raie A, Shioda N, Qin ZH, Fukunaga K (2008) Accumulation of beta-amyloid in the brain microvessels accompanies increased hyperphosphorylated tau proteins following microsphere embolism in aged rats. Neuroscience 153, 414-427.
75. Luth HJ, Munch G, Arendt T (2002) Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation. Brain Res 953, 135-143.
76. Liu HX, Zhang JJ, Zheng P, Zhang Y (2005) Altered expression of MAP-2, GAP-43, and synaptophysin in the hippocampus of rats with chronic cerebral hypoperfusion correlates with cognitive impairment. Brain Res Mol Brain Res 139, 169-177.
77. Wang X, Xing A, Xu C, Cai Q, Liu H, Li L (2010) Cerebrovascular hypoperfusion induces spatial memory impairment, synaptic changes, and amyloid-beta oligomerization in rats. J Alzheimers Dis 21, 813-822.
78. Ni JW, Matsumoto K, Li HB, Murakami Y, Watanabe H (1995) Neuronal damage and decrease of central acetylcholine level following permanent occlusion of bilateral common carotid arteries in rat. Brain Res 673, 290-296.
79. Cada A, de la Torre JC, Gonzalez-Lima F (2000) Chronic cerebrovascular ischemia in aged rats: Effects on brain metabolic capacity and behavior. Neurobiol Aging 21, 225-233.
80. Hall ED, Oostveen JA, Dunn E, Carter DB (1995) Increased amyloid protein precursor and apolipoprotein E immunoreactivity in the selectively vulnerable hippocampus following transient forebrain ischemia in gerbils. Exp Neurol 135, 17-27.
81. Orth M, Bellosta S (2012) Cholesterol: Its regulation and role in central nervous system disorders. Cholesterol 2012, 292598.
82. Erickson MA, Hartvigson PE, Morofuji Y, Owen JB, Butterfield DA, Banks WA (2012) Lipopolysaccharide impairs amyloid beta efflux from brain: Altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier. J Neuroinflammation 9, 150.
83. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman DM, Miller CA, Strickland DK, Ghiso J, Zlokovic BV (2000) Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptorrelated protein-1 at the blood-brain barrier. J Clin Invest 106, 1489-1499.
84. Tamaki C, Ohtsuki S, Iwatsubo T, Hashimoto T, Yamada K, Yabuki C, Terasaki T (2006) Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid beta-peptide by the liver. Pharm Res 23, 1407-1416.
85. Herz J, Strickland DK (2001) LRP: A multifunctional scavenger and signaling receptor. J Clin Invest 108, 779-784.
86. Deane R, Wu Z, Sagare A, Davis J, Du Yan S, Hamm K, Xu F, Parisi M, LaRue B, Hu HW, Spijkers P, Guo H, Song X, Lenting PJ,Van Nostrand WE, Zlokovic BV (2004) LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 43, 333-344.
87. Spuch C, Ortolano S, Navarro C (2012) LRP-1 and LRP-2 receptors function in the membrane neuron. Trafficking mechanisms and proteolytic processing in Alzheimer's disease. Front Physiol 3, 269.
88. Hawkes CA, Sullivan PM, Hands S, Weller RO, Nicoll JA, Carare RO (2012) Disruption of arterial perivascular drainage of amyloid-beta from the brains of mice expressing the human APOE epsilon4 allele. PLoS One 7, e41636.
89. Kamada H, Sato K, Zhang WR, Omori N, Nagano I, Shoji M, Abe K (2003) Spatiotemporal changes of apolipoprotein Eimmunoreactivity and apolipoproteinEmRNAexpression after transient middle cerebral artery occlusion in rat brain. J Neurosci Res 73, 545-556.
90. Gandy S, Haroutunian V, DeKosky ST, Sano M, Schadt EE (2013) CR1 and the "vanishing amyloid" hypothesis of Alzheimer's disease. Biol Psychiatry 73, 393-395.
91. Gandy S, Heppner FL (2013) Microglia as dynamic and essential components of the amyloid hypothesis. Neuron 78, 575-577.
92. Griciuc A, Serrano-Pozo A, Parrado AR, Lesinski AN, Asselin CN, Mullin K, Hooli B, Choi SH, Hyman BT, Tanzi RE (2013) Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 78, 631-643.
93. Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, Rujescu D, Hampel H, Giegling I, Andreassen OA, Engedal K, Ulstein I, Djurovic S, Ibrahim-Verbaas C, Hofman A, Ikram MA, van Duijn CM, Thorsteinsdottir U,Kong A, Stefansson K (2013) Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med 368, 107-116.
94. Thambisetty M, An Y, Nalls M, Sojkova J, Swaminathan S, Zhou Y, Singleton AB, Wong DF, Ferrucci L, Saykin AJ, Resnick SM (2013) Effect of complement CR1 on brain amyloid burden during aging and its modification by APOE genotype. Biol Psychiatry 73, 422-428.
95. Brouwers N, Van Cauwenberghe C, Engelborghs S, Lambert JC, Bettens K, Le Bastard N, Pasquier F, Montoya AG, Peeters K, Mattheijssens M, Vandenberghe R, Deyn PP, Cruts M, Amouyel P, Sleegers K, Van Broeckhoven C (2012) Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites. Mol Psychiatry 17, 223-233.
96. Chibnik LB, Shulman JM, Leurgans SE, Schneider JA,Wilson RS, Tran D, Aubin C, Buchman AS, Heward CB, Myers AJ, Hardy JA, Huentelman MJ, Corneveaux JJ, Reiman EM, Evans DA, Bennett DA, De Jager PL (2011) CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann Neurol 69, 560-569.
97. Kalaria RN (2000) The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 21, 321-330.
98. Johnson VE, Stewart W, Smith DH (2010) Traumatic brain injury and amyloid-beta pathology: A link to Alzheimer's disease Nat Rev Neurosci 11, 361-370.
99. Blumbergs PC, Scott G, Manavis J, Wainwright H, Simpson DA,McLean AJ (1995) Topography of axonal injury as defined by amyloid precursor protein and the sector scoring method in mild and severe closed head injury. J Neurotrauma 12, 565-572.
100. Iwata A, Chen XH, McIntosh TK, Browne KD, Smith DH (2002) Long-term accumulation of amyloid-beta in axons following brain trauma without persistent upregulation of amyloid precursor protein genes. J Neuropathol Exp Neurol 61, 1056-1068.
101. Gorrie C, Oakes S, Duflou J, Blumbergs P, Waite PM (2002) Axonal injury in children after motor vehicle crashes: Extent, distribution, and size of axonal swellings using beta-APPimmunohistochemistry. J Neurotrauma 19, 1171-1182.
102. Reichard RR, White CL, 3rd, Hladik CL, Dolinak D (2003) Beta-amyloid precursor protein staining of nonaccidental central nervous system injury in pediatric autopsies. J Neurotrauma 20, 347-355.
103. Murai H, Pierce JE, Raghupathi R, Smith DH, Saatman KE, Trojanowski JQ, Lee VM, Loring JF, Eckman C, Younkin S, McIntosh TK (1998) Twofold overexpression of human beta-amyloid precursor proteins in transgenic mice does not affect the neuromotor, cognitive, or neurodegenerative sequelae following experimental brain injury. J Comp Neurol 392, 428-438.
104. Smith DH, Nakamura M, McIntosh TK,Wang J, Rodriguez A, Chen XH, Raghupathi R, Saatman KE, Clemens J, Schmidt ML, Lee VM, Trojanowski JQ (1998) Brain trauma induces massive hippocampal neuron death linked to a surge in beta-amyloid levels in mice overexpressing mutant amyloid precursor protein. Am J Pathol 153, 1005-1010.
105. Tran HT, LaFerla FM, Holtzman DM, Brody DL (2011) Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-beta accumulation and independently accelerates the development of tau abnormalities. J Neurosci 31, 9513-9525.
106. Smith DH, Chen XH, Nonaka M, Trojanowski JQ, Lee VM, Saatman KE, Leoni MJ,Xu BN, Wolf JA, Meaney DF (1999) Accumulation of amyloid beta and tau and the formation of neurofilament inclusions following diffuse brain injury in the pig. J Neuropathol Exp Neurol 58, 982-992.
107. Xu SY, Pan SY (2013) The failure of animal models of neuroprotection in acute ischemic stroke to translate to clinical efficacy. Med Sci Monit Basic Res 19, 37-45.
108. Cook DJ, Tymianski M (2012) Nonhuman primate models of stroke for translational neuroprotection research. Neurotherapeutics 9, 371-379.
109. Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D, Yednock T (2000) Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 6, 916-919.
110. Schuff N, Matsumoto S, Kmiecik J, Studholme C, Du A, Ezekiel F, Miller BL, Kramer JH, Jagust WJ, Chui HC, Weiner MW (2009) Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging. Alzheimers Dement 5, 454-462.
111. Sagare A, Deane R, Bell RD, Johnson B,HammK, Pendu R, Marky A, Lenting PJ, Wu Z, Zarcone T, Goate A, Mayo K, Perlmutter D,ComaM,Zhong Z, ZlokovicBV(2007) Clearance of amyloid-beta by circulating lipoprotein receptors. Nat Med 13, 1029-1031.
112. Zlokovic BV (2011) Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 12, 723-738.